1. Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy
    Kerstin Zwirner et al, 2018, Radiotherapy and Oncology CrossRef
  2. Risk assessment of febrile neutropenia and evaluation of G-CSF use in patients with cancer: a real-life study
    Elif Aras et al, 2020, Supportive Care in Cancer CrossRef
  3. Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim
    Pere Gascon et al, 2019, BioDrugs CrossRef
  4. Commentary - A comprehensive safety understanding of granulocyte-colony stimulating factor biosimilars and Intended Copy Biologics in treating chemotherapy associated febrile neutropenia
    P.G. Cornes et al, 2020, Toxicology and Applied Pharmacology CrossRef